Table 2 Drugs given at induction and continued in the postoperative period
patients | Name of drug | dose | Manufacturer |
|---|---|---|---|
Patient 1 | Vancomycin (Vancocin cp) | 0.5 g q12h for 10 days | Eli Lilly and Company |
Patient 2 | Cefuroxime (Zinacef) | 1.5 g 2 h before operation and 48 h after operation | Glaxo Wellcome Op |
Ornidazole (TUOSU) | 0.5 g 2 h before operation and 48 h after operation | Sichuang Kelun Pharmaceutical Co. Ltd | |
Pantoprazole (TIANLONG) | 40 mg 48 h after operation | Liaoning Tianlong Pharmaceutical Co. Ltd | |
Patient 3 | Ceftriaxone sodium Tazobactam sodium (YOUTANENG) | 2 g 2 h before operation and 48 h after operation | Haikou Qili Pharmaceutical Co. Ltd |
Omeprazole (AOXIKANG) | 40 mg 48 h after operation | Jiangsu Aosaikang Pharmaceutical Co. Ltd | |
Patient 4 | Ceftriaxone sodium Tazobactam sodium (YOUTANENG) | 2 g 2 h before operation and 36 h after operation | Haikou Qili Pharmaceutical Co. Ltd |
Omeprazole (AOXIKANG) | 40 mg 72 h after operation | Jiangsu Aosaikang Pharmaceutical Co. Ltd | |
Patient 5 | ceftazidime (Fortum) | 2 g 2 h before operation and 72 h after operation | GlaxoSmithKline plc |
Pantoprazole (Pantoloc) | 40 mg 48 h after operation | Nycomed GmbH |